The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+ selected allogeneic stem cell transplant Journal Article


Authors: Alarcon Tomas, A.; Whiting, K.; Maloy, M.; Ruiz, J. D.; Devlin, S.; Sanchez-Escamilla, M.; Yañez, L.; Castillo, N.; Pennisi, M.; Cho, C.; Shaffer, B.; Castro-Malaspina, H.; Klimek, V.; Giralt, S. A.; Tamari, R.; Perales, M. A.
Article Title: The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+ selected allogeneic stem cell transplant
Abstract: The post-transplant scoring system (PTSS), developed by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy, is based on three independent post-transplant risk factors: grade of acute graft-versus-host disease, lack of platelet recovery before day 100, and relapse before day 100; discriminating low- (0), intermediate- (1–3), and high-risk (4–8) patients. We investigated the prognostic value of the PTSS in a cohort of patients with MDS who underwent myeloablative CD34-selected TCD transplants. From 2008 to 2018, 109 patients underwent a first TCD-HCT for MDS at our center. We used Cox proportional hazards models and different landmark analyses to evaluate the association of categorized PTSS score risk groups with overall survival (OS). Patients with an intermediate/ high risk PTSS score had decreased OS at day 180 (univariate HR 3.25 [95% CI 1.60, 6.60], p = 0.001) and at day 365 (univariate HR 5.42 [95% CI 2.21, 13.3], p < 0.001) compared to low risk PTSS scores. This association remained significant after adjusting for HCT-CI. PTSS score calculated at day 100 was not associated with OS, even after adjusting for HCT-CI subgroups. In summary, the PTSS predicted survival at day 180 and day 365 in recipients of T-cell-depleted allografts for myelodysplastic syndrome. © 2021, The Author(s), under exclusive licence to Springer Nature Limited.
Journal Title: Bone Marrow Transplantation
Volume: 56
Issue: 11
ISSN: 0268-3369
Publisher: Nature Publishing Group  
Date Published: 2021-11-01
Start Page: 2749
End Page: 2754
Language: English
DOI: 10.1038/s41409-021-01392-w
PUBMED: 34253878
PROVIDER: scopus
PMCID: PMC8273566
DOI/URL:
Notes: Article -- Export Date: 1 December 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Virginia Klimek
    147 Klimek
  2. Sergio Andres Giralt
    1050 Giralt
  3. Miguel-Angel Perales
    913 Perales
  4. Molly Anna Maloy
    269 Maloy
  5. Sean McCarthy Devlin
    601 Devlin
  6. Christina Cho
    134 Cho
  7. Roni Tamari
    208 Tamari
  8. Brian Carl Shaffer
    164 Shaffer
  9. Karissa A. Whiting
    47 Whiting
  10. Josel Dumo Ruiz
    54 Ruiz
  11. Martina Pennisi
    25 Pennisi